Market Cap
Danaher Corporation
$177.21 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $204.45 B |
Siemens Healthineers AG | $63.84 B |
DexCom, Inc. | $45.21 B |
Lonza Group Ltd | $39.85 B |
IDEXX Laboratories, Inc. | $39.43 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Danaher Corporation is a diversified multinational company providing professional, medical, industrial, and commercial products and services. It is especially involved in the design, manufacturing, and commercialization of medical and laboratory instruments for medical diagnosis, as well as specialized equipment, consumables, and software for the biopharmaceutical, packaging, food and beverage, aerospace, microelectronics, water utilities, and general industrial sectors.
Danaher Corporation has the following listings and related stock indices.
Stock: NYSE: DHR
Stock: BMV: DHR
Stock: Bovespa: DHER34
Stock: FSX: DAP
Stock: NYSE: DHR.PR.A
Stock: NYSE: DHR.PR.B
Stock: NYSE: DHR-A
Stock: XETR: DAP
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.